09/2024

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

09/2024

Sep 28, 2024, 08:01 | Blog
How to redesign support tools and care paths for cancer patients - European Cancer Organisation
European Cancer Organisation shared on LinkedIn: "Want to know more about improving care for cancer…
Sep 28, 2024, 07:32 | Blog
Wear Gold Day is here - AIEOP
Italian Association for Pediatric Hematology-Oncology (AIEOP) shared on LinkedIn: "WEAR GOLD DAY IS HERE!   AIEOP…
Sep 28, 2024, 07:26 | Blog
Rajinder Kaur Saggu on Guide to Managing Breast Pain
Rajinder Kaur Saggu, Breast Surgeon, Director Breast Oncosurgery, Max Institute of Cancer Care, shared a post…
Sep 28, 2024, 07:23 | Blog
SIOP Europe is at the Joint Action on Networks of Expertise
SIOP Europe shared a post on LinkedIn: "SIOP Europe is at the JANE, An Ambitious Vision…
Sep 28, 2024, 07:18 | Blog
Multinational Association of Supportive Care in Cancer is offering a number of awards and scholarships for successful abstract submissions
Multinational Association of Supportive Care in Cancer shared a post on LinkedIn: "Did you know…
Sep 28, 2024, 07:16 | Blog
Tracey O’Brien: Incredibly humbling to be recognised with such a prestigious national award
Tracey O’Brien shared a post on LinkedIn: "Yesterday, I had the honor of attending my investiture…
Sep 28, 2024, 07:13 | Blog
Stephen V Liu: Very different healthcare systems - very similar challenges and unanswered questions
Stephen V Liu shared a post on X: "Thanks to colleagues in China for a great…
Sep 28, 2024, 07:08 | Blog
Jordan Berlin: Another case of making cancer care personal
Jordan Berlin, Oncologist at Vanderbilt University Medical Center, shared a post by Vanderbilt-Ingram Cancer Center on…
Sep 28, 2024, 07:02 | Blog
Rahul Gosain: Osimertinib now FDA approved after LAURA Phase III study
Rahul Gosain shared the following on LinkedIn: “Osimertinib now FDA approved based off LAURA: Ph III,…
Sep 28, 2024, 06:59 | Blog
Shubh Goel: AstraZeneca’s ambition in oncology aims for a future where cancer is no longer a cause of death
Shubh Goel, VP and US Franchise Head, Immuno-Oncology and GI Tumors at AstraZeneca, shared a post…
All: 2508 Posts: 221 - 230
Special Coverage